SPONSORED: BURDICK, WELCH ALLYN
Three ways to show your customers the value
The facts are clear.
- Heart disease is the leading cause of death in the United States.1
- COPD is a major cause of disability, and it is the third leading cause of death in the United States.2
- Stroke is the fifth leading cause of death in the United States, killing more than 130,000 Americans each year – that’s 1 of every 20 deaths.3
Your primary care customers treat patients with chronic cardiopulmonary conditions every day. Are you up to speed on the latest devices to help screen for and diagnose these conditions in primary care settings?
Here are three powerful strategies to prove the value of cardiopulmonary screening and diagnosis in primary care:
- Empower them to improve patient outcomes by conducting more procedures in primary care, rather than referring to specialists.
Present resting ECG, stress ECG, holter, spirometry and ambulatory blood pressure monitoring devices that are designed with primary care clinicians in mind. Focus on intuitive user interfaces and flexible report outputs. More procedures in primary care means patients spend less time waiting for specialist referrals. That time could have a large impact on time to diagnosis and, thus, time to treatment. - Be their hero by offering a connectivity solution designed for their workflows – not a specialist’s.
EMR connectivity is a given; it’s the “how” that can make the difference. Ask about their workflows and preferred communication protocols. Wireless communication may be music to their ears because it will make it easier to move devices wherever they are needed. Or perhaps they have a strong leader in IT pushing for DICOM conformance. Go beyond checking the box on connectivity and find the solution that best fits each practice’s needs.
- Show them the potential to improve financial outcomes.
Every time your customer refers a patient to a specialist, potential reimbursement revenue walks out the door with them. Offering these procedures in primary care can have significant impact on practice revenues. And when it comes to IDNs, the value of conducting these procedures in lower-cost primary care settings rather than higher-cost specialist settings can be significant.
Your primary care customers represent the front lines of a complex healthcare system, and they are dealing with chronic cardiopulmonary conditions every day. Help them prove the value of offering more screening in primary care, with devices designed for primary care.
And remember: we’re here to help. Contact your Welch Allyn representative to learn more about our full line of cardiopulmonary devices – now including Mortara products. Learn more at www.welchallyn.com.
1 Mozzafarian D, Benjamin EJ, Go AS, et al. on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics –2016 update: a report from the American Heart Association. Circulation. 2016;133:e38-e360.
2 https://www.nhlbi.nih.gov/health/health-topics/topics/copd
3 Centers for Disease Control and Prevention, National Center for Health Statistics. Underlying Cause of Death 1999-2013 on CDC WONDER Online Database, released 2015. Data are from the Multiple Cause of Death Files, 1999-2013, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program: http://wonder.cdc.gov/ucd-icd10.html. Accessed on Feb 3, 2015.